Validation of the Healthcare Relationship Assessment Scale (ERA) in Health Sciences Students. (COPS-ERA)

November 3, 2026 updated by: Universidad Loyola Andalucia

Validation of an Instrument for the Assessment of the Healthcare Relationship (ERA Scale) in Health Sciences Students During Clinical Placements

This study aims to design and psychometrically validate a practical and agile observational instrument-the Healthcare Relationship Assessment scale (ERA scale)-to evaluate communication skills and person-centered care among undergraduate health sciences students (Nursing, Physiotherapy, Pharmacy, and Psychology) during their external clinical placements. Adapted from the theoretical framework of the CICAA scale, the instrument is designed to reduce evaluation burden for clinical mentors while maintaining high measurement reliability and validity.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

erson-centered care requires healthcare professionals to master relational and communication competencies. Although clinical placements represent an ideal setting to train and assess these skills, existing tools like the CICAA scale present logistical challenges due to the extensive training and observation time required from clinical tutors. This sequential mixed-methods study comprises two phases: Qualitative phase: Semi-structured interviews with academic coordinators, clinical tutors, and recent graduates/students to refine item content, operational feasibility, and relevance based on the four CICAA dimensions (connecting, identifying/understanding health issues, agreeing on decisions/actions, and assisting in understanding and acting). Quantitative phase: A cross-sectional observational study where clinical tutors evaluate students at the end of their clinical placements using the ERA scale via Qualtrics. Psychometric evaluation will include Exploratory and Confirmatory Factor Analysis (CFI, TLI, RMSEA), internal consistency (Cronbach's alpha, McDonald's omega), inter-rater reliability, and response-process validity (paradata/response latencies).

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Raquel Ruiz-Íñiguez, PhD
  • Phone Number: +34 955 641 600
  • Email: rruiz@uloyola.es

Study Contact Backup

  • Name: Diego Díaz-Milanés, PhD
  • Phone Number: +34 955 641 600
  • Email: rruiz@uloyola.es

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Undergraduate health sciences students from Nursing, Physiotherapy, Pharmacy, and Psychology degrees undergoing curricular external clinical placements across affiliated hospitals, primary healthcare centers, educational centers, and social health organizations, along with their assigned clinical tutors and academic practicum coordinators

Description

Students (evaluated participants):

  • Undergraduate students actively enrolled in Nursing (years 1 to 4), Physiotherapy (years 3 to 4), Pharmacy (years 3 to 4), or Psychology (year 3).
  • Currently completing external clinical placements or clinical practicum in affiliated healthcare, educational, or social settings.
  • Sufficient linguistic competence in Spanish.
  • Provision of explicit electronic informed consent for the use of observational evaluation data for research purposes.

Clinical Tutors and Key Informants:

  • Active clinical healthcare professionals serving as clinical tutors/mentors for students during their practicum.
  • For the qualitative phase: Academic coordinators, clinical tutors, or university professors with at least one year of experience in clinical tutoring or academic management of clinical placements, and no more than five years of teaching inactivity in this area.
  • For the qualitative phase (graduates/students): Healthcare graduates or senior students who completed clinical practicum within the past two to three years.
  • Provision of signed or electronic informed consent.

Exclusion Criteria:

  • Students not actively undertaking clinical placements during the study evaluation periods.
  • Refusal to provide informed consent or withdrawal of consent at any point during data collection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: CROSS_SECTIONAL

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Health Sciences Students

Undergraduate students enrolled in Nursing (years 1-4), Physiotherapy (years 3-4), Pharmacy (years 3-4), and Psychology (year 3) during their external clinical placements across affiliated health and social care centers. Their interpersonal communication and person-centered relational skills are evaluated observationally by their designated clinical tutors

An observational assessment tool adapted from the CICAA model to evaluate communication competencies and person-centered care in healthcare students during clinical practicum. The instrument is completed online via Qualtrics by clinical tutors once at the end of the student's clinical placement period (taking approximately 10 minutes).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Construct Validity and Internal Structure of the ERA Scale
Time Frame: At the completion of each student's clinical placement period (approximately end of semester / academic year, up to 10 months).

Goodness-of-fit indices evaluated via Exploratory and Confirmatory Factor Analysis (CFI ≥ 0.95, TLI ≥ 0.95, RMSEA ≤ 0.06) based on tutor ratings of student communication and relationship skills

At the completion of each student's clinical placement period (approximately end of semester / academic year, up to 10 months).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inter-Rater Reliability of the ERA Scale
Time Frame: Through the end of the academic evaluation cycle (up to 12 months).

Degree of agreement between clinical observers evaluated using the Intraclass Correlation Coefficient (ICC) or weighted Kappa coefficient.

Through the end of the academic evaluation cycle (up to 12 months).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Raquel Ruiz-Íñiguez, PhD, Universidad Loyola Andalucia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

October 26, 2026

First Submitted That Met QC Criteria

October 26, 2026

First Posted (Actual)

November 2, 2026

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 3, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 260903 CE26897

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

In accordance with the study protocol approved by the institutional ethics committee and the participant informed consent agreements, raw individual participant data will remain strictly confidential and will not be shared with outside parties or third-party researchers. Study results will be disseminated exclusively as aggregated data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.